JRSDX
Price
$12.35
Change
+$0.08 (+0.65%)
Updated
Aug 8 closing price
Net Assets
618.63M
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

JRSDX vs VSTSX

Header iconJRSDX vs VSTSX Comparison
Open Charts JRSDX vs VSTSXBanner chart's image
JH Adaptive Risk Mgd U.S. Eq D
Price$12.35
Change+$0.08 (+0.65%)
VolumeN/A
Net Assets618.63M
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
JRSDX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JRSDX vs. VSTSX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRSDX is a StrongBuy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. JRSDX (619M). VSTSX pays higher dividends than JRSDX: VSTSX (1.20) vs JRSDX (1.10). JRSDX was incepted earlier than VSTSX: JRSDX (11 years) vs VSTSX (9 years). JRSDX (0.70) is less costly to investors than VSTSX (0.01). JRSDX is a more actively managed with annual turnover of: 250.00 vs. VSTSX (2.00). JRSDX has a lower initial minimum investment than VSTSX: JRSDX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 18.91 vs. JRSDX (15.13). VSTSX return over 5 years is better than : 83.88 vs. JRSDX (6.85).
JRSDXVSTSXJRSDX / VSTSX
Total Expense Ratio0.700.017,000%
Annual Report Gross Expense Ratio0.700.017,000%
Fund Existence11 years9 years-
Gain YTD6.8347.37193%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets619M1.91T0%
Annual Yield % from dividends1.101.2092%
Returns for 1 year15.1318.9180%
Returns for 3 years38.5751.0476%
Returns for 5 years6.8583.888%
Returns for 10 years54.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited